Eksponeringen for rivastigmin og dets metabolit svarede omtrent til human eksponering med de højeste doser rivastigminkapsler og - depotplastre.
The exposure to rivastigmine and its metabolites was approximately equivalent to human exposure with highest doses of rivastigmine capsules and transdermal patches.